Custom Search


Thursday 22 May 2008

Barrier Therapeutics Announces Agreement with Procter & Gamble to Market Xolegel (ketoconazole, USP) Gel, 2 Percent With Head & Shoulders Shampoo as Xolegel Duo

By: Prime Newswire

Barrier Therapeutics, Inc., a pharmaceutical company developing and commercializing products in the field of therapeutic dermatology, announced that it will package its seborrheic dermatitis treatment Xolegel(r) (ketoconazole, USP) Gel, 2%, with The Procter & Gamble Company's (NYSE:PG) Head & Shoulders(r) (pyrithione zinc 1%) anti-dandruff shampoo as Xolegel Duo(tm). The kit, which will be available by prescription in June, offers patients a complete treatment regimen for seborrheic dermatitis, a recurring inflammatory skin condition characterized by a red, scaly, itchy rash primarily on the face, scalp, hairline, eyebrows and torso.

"We're pleased to include Head & Shoulders shampoo, one of P&G's most trusted brands, in our Xolegel Duo," said Al Altomari, Chief Executive Officer of Barrier Therapeutics. "With an estimated 90% of patients with seborrheic dermatitis believed to have affected areas on the scalp as well as on the face and body, this complete treatment system can help patients effectively manage this irritating and often embarrassing condition."

Under the terms of the deal, P&G will supply Barrier Therapeutics with 1.7oz bottles of Head & Shoulders shampoo for inclusion in Xolegel Duo(tm) and Barrier Therapeutics will handle all logistics of assembling the kits, as well as wholesaler distribution, pricing, and overall marketing, promotion and sale. Barrier Therapeutics will continue to book sales and receive all proceeds from the sale of Xolegel Duo.

Xolegel Duo is designed to provide a more complete treatment option for effectively managing seborrheic dermatitis by providing a prescription gel formulation of ketoconazole for the face and body plus a medicated shampoo for the scalp in one convenient package. Barrier Therapeutics launched Xolegel Duo, a kit containing Xolegel and Xolex(tm) (zinc pyrithione 1%) an anti-dandruff shampoo, at the American Academy of Dermatology last August. Until then, physicians typically recommended two distinct products for patients suffering from seborrheic dermatitis, one product for the scalp and a different product for the face and body.

View the complete article

Use of this site is subject to the following terms of use